GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Selling and Marketing Expense

Perrigo Co (BSP:P1RG34) Selling and Marketing Expense : R$3,593 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Perrigo Co's Selling and Marketing Expense for the three months ended in Mar. 2024 was R$872 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was R$3,593 Mil.

Perrigo Co Selling and Marketing Expense Historical Data

The historical data trend for Perrigo Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Selling and Marketing Expense Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,547.66 3,244.25 3,559.19 3,660.24 3,686.12

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,023.49 969.28 879.09 872.65 872.46

Perrigo Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3,593 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Perrigo Co (BSP:P1RG34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Selling and Marketing Expense
Comparable Companies
ALKS LNTH ALVO PBH ELAN AMPH AMRX SUPN AVDL TARO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
PRGO:USA PIG:Germany
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Website
https://www.perrigo.com
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines